Vyjayanthi Krishnan

458 total citations
9 papers, 241 citations indexed

About

Vyjayanthi Krishnan is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Vyjayanthi Krishnan has authored 9 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in Vyjayanthi Krishnan's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (2 papers). Vyjayanthi Krishnan is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (2 papers). Vyjayanthi Krishnan collaborates with scholars based in United States. Vyjayanthi Krishnan's co-authors include Steven L. Zeichner, Naoto Yoshizuka, Syed Shaheduzzaman, Jeffrey M. Trent, Sundararajan Venkatesan, Paul S. Meltzer, Ana G. Petrovic, Michael Bittner, M. Scot Roberts and Katie Anderson and has published in prestigious journals such as Journal of Virology, Journal of Hepatology and Journal of Biomedical Science.

In The Last Decade

Vyjayanthi Krishnan

9 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vyjayanthi Krishnan United States 6 126 103 99 65 44 9 241
Gilberto Betancor United Kingdom 11 213 1.7× 116 1.1× 154 1.6× 95 1.5× 60 1.4× 16 316
Li Ren China 9 92 0.7× 102 1.0× 62 0.6× 87 1.3× 65 1.5× 33 252
Slim Fourati United States 6 81 0.6× 66 0.6× 120 1.2× 105 1.6× 73 1.7× 13 281
Scott Butler United States 4 135 1.1× 126 1.2× 168 1.7× 22 0.3× 47 1.1× 5 240
Mako Toyoda Japan 8 95 0.8× 48 0.5× 87 0.9× 67 1.0× 34 0.8× 19 169
Melanie Kremer Germany 10 86 0.7× 65 0.6× 53 0.5× 69 1.1× 86 2.0× 12 261
Peter Buontempo United States 9 111 0.9× 89 0.9× 204 2.1× 96 1.5× 99 2.3× 16 366
John Bui United States 5 184 1.5× 81 0.8× 107 1.1× 158 2.4× 72 1.6× 9 295
Ralf Duerr United States 9 104 0.8× 58 0.6× 206 2.1× 48 0.7× 48 1.1× 35 295
Jori Symons Australia 10 150 1.2× 77 0.7× 141 1.4× 98 1.5× 102 2.3× 14 296

Countries citing papers authored by Vyjayanthi Krishnan

Since Specialization
Citations

This map shows the geographic impact of Vyjayanthi Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vyjayanthi Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vyjayanthi Krishnan more than expected).

Fields of papers citing papers by Vyjayanthi Krishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vyjayanthi Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vyjayanthi Krishnan. The network helps show where Vyjayanthi Krishnan may publish in the future.

Co-authorship network of co-authors of Vyjayanthi Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Vyjayanthi Krishnan. A scholar is included among the top collaborators of Vyjayanthi Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vyjayanthi Krishnan. Vyjayanthi Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Tasker, Sybil, Stephan Bart, Vyjayanthi Krishnan, et al.. (2021). Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial. Vaccines. 9(3). 224–224. 15 indexed citations
3.
Tasker, Sybil, et al.. (2018). 2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine. Open Forum Infectious Diseases. 5(suppl_1). S68–S68. 4 indexed citations
4.
Krishnan, Vyjayanthi, et al.. (2015). Efficacy and Immunogenicity of Single-Dose AdVAV Intranasal Anthrax Vaccine Compared to Anthrax Vaccine Absorbed in an Aerosolized Spore Rabbit Challenge Model. Clinical and Vaccine Immunology. 22(4). 430–439. 17 indexed citations
5.
Yoshizuka, Naoto, et al.. (2005). Human Immunodeficiency Virus Type 1 Vpr-Dependent Cell Cycle Arrest through a Mitogen-Activated Protein Kinase Signal Transduction Pathway. Journal of Virology. 79(17). 11366–11381. 31 indexed citations
6.
7.
Krishnan, Vyjayanthi & Steven L. Zeichner. (2004). Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication. Retrovirology. 1(1). 46 indexed citations
8.
Shaheduzzaman, Syed, Vyjayanthi Krishnan, Ana G. Petrovic, et al.. (2002). Effects of HIV-1 nef on cellular gene expression profiles. Journal of Biomedical Science. 9(1). 82–96. 29 indexed citations
9.
Shaheduzzaman, Syed, Vyjayanthi Krishnan, Ana G. Petrovic, et al.. (2002). Effects of HIV-1 Nef on Cellular Gene Expression Profiles. Journal of Biomedical Science. 9(1). 82–96. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilberto Betancor Breakdown of academic impact, for papers by Li Ren Breakdown of academic impact, for papers by Slim Fourati Breakdown of academic impact, for papers by Scott Butler Breakdown of academic impact, for papers by Mako Toyoda Breakdown of academic impact, for papers by Melanie Kremer Breakdown of academic impact, for papers by Peter Buontempo Breakdown of academic impact, for papers by John Bui Breakdown of academic impact, for papers by Ralf Duerr Breakdown of academic impact, for papers by Jori Symons
Rankless by CCL
2026